| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $25.2B | $22.1B | $20.4B | $19.7B | $17.9B | $15.2B | $3.8B | $3.8B |
| Cost of Revenue | $15.0B | $13.4B | $12.6B | $12.3B | $11.1B | $9.3B | $9.5B | $9.2B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $2.7B | $2.3B | $1.9B | $1.9B | $1.9B | $1.7B | $1.6B | $1.5B |
| Operating Income | $4.3B | $4.1B | $3.6B | $3.4B | $3.0B | $2.4B | $0.7B | $0.8B |
| Net Income | $2.7B | $2.7B | $2.3B | $2.2B | $1.8B | $1.5B | $0.4B | $0.5B |
| EPS (Basic) | $6.72 | $6.84 | $5.69 | $5.42 | $4.32 | $3.54 | $1.05 | $1.25 |
| EPS (Diluted) | $6.70 | $6.81 | $5.66 | $5.39 | $4.29 | $3.52 | $1.05 | $1.24 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $45.8B | $44.6B | $32.8B | $31.4B | $29.1B | $29.3B | $27.7B | $22.6B |
| Current Assets | $4.9B | $4.8B | $3.8B | $3.6B | $3.1B | $3.5B | $6.2B | $2.6B |
| Cash & Equivalents | $0.2B | $0.4B | $0.5B | $0.4B | $0.1B | $0.6B | $3.6B | $0.1B |
| Total Liabilities | $35.8B | $36.3B | $25.9B | $24.5B | $22.0B | $21.9B | $20.7B | $16.4B |
| Current Liabilities | $5.5B | $6.3B | $4.2B | $4.4B | $4.1B | $3.6B | $3.1B | $3.1B |
| Stockholders' Equity | $10.0B | $8.3B | $6.9B | $6.8B | $7.1B | $7.5B | $7.1B | $6.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $6.0B | $5.4B | $4.7B | $4.5B | $4.3B | $3.4B | $3.9B | $3.6B |
| Investing Cash Flow | $-3.6B | $-10.6B | $-3.1B | $-3.1B | $-1.9B | $-4.8B | $-2.4B | $-2.2B |
| Capital Expenditures | — | — | — | $2.8B | $2.0B | $1.6B | $1.8B | $1.7B |
| Financing Cash Flow | $-2.7B | $5.2B | $-1.5B | $-1.2B | $-2.9B | $-1.6B | $2.0B | $-1.5B |